comparemela.com

Latest Breaking News On - Segmentation by route of administration - Page 11 : comparemela.com

Anesthetics Global Market Report 2023 Featuring Abbott

Dublin, Feb. 23, 2023 (GLOBE NEWSWIRE) The "Anesthetics Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering.The.

United statesUnited kingdomEstado de pernambucoSouth koreaB braun melsungenEisai coPacira pharmaceuticals incAbbvie incNovartis internationalBoehringer ingelheim international gmbHameln pharmaceuticalsFresenius se coSegmentation by route of administrationPiramal groupMaruishi pharmaceuticalsAmerican society of anesthesiologists

Insights on the Topical Drug Delivery Global Market to 2031 - Players Include Glenmark Pharmaceuticals, Galderma, Johnson & Johnson and GlaxoSmithKline

/PRNewswire/ The "Topical Drug Delivery Global Market Report 2022: Ukraine-Russia War Impact" report has been added to ResearchAndMarkets.com s offering..

United statesUnited kingdomSouth koreaMerck coincAsia pacificLaura woodCipla ltdValeant pharmaceuticals international incGlaxosmithkline plcEncore dermatology incJohnson privatePfizer incMedpharm groupCrescita therpeautics incNovartis internationalBayer ag

Global Inflammatory Bowel Disease Treatment Market Research

Dublin, Nov. 08, 2022 (GLOBE NEWSWIRE) The "Inflammatory Bowel Disease Treatment Global Market Report 2022" report has been added to .

United statesEli lillyBausch health companies incJanssen biotech incAlkem laboratoriesFerring pharmaceuticalsMerck coSegmentation by route of administrationTakeda pharmaceutical companyPfizer incAmgen incAbbvie incAbbott laboratoriesBowel disease treatment global market reportWestern europeEastern europe

Global TNF Alpha Inhibitors Market Report 2022-2026 & 2031

Dublin, Aug. 04, 2022 (GLOBE NEWSWIRE) The "TNF Alpha Inhibitors Global Market Report 2022: By Drug, By Route, By Disease" report has been added to.

United statesUnited kingdomSouth koreaAryogen biopharmaHanall biopharmaZydus cadilaSamsung bioepisCelgene corporationMomenta pharmaceuticalsReliance life sciencesDrug administrationSegmentation by route of administrationPfizer incIntas pharmaceuticalsAmgen incAbbvie inc

Global Antisense & RNAi Therapeutics Market Report 2022: A $2 14 Billion Market in 2026 from $1 42 Billion in 2022

/PRNewswire/ The "Antisense & RNAi Therapeutics Global Market Report 2022: By Technology, By Route, By Indication" report has been added to.

United statesUnited kingdomSouth koreaVolgogradskaya oblastAptose biosciencesCenix bioscienceMarina biosciencesLaura woodNational institute of environmental health sciencesGlaxosmithkline plcOlix pharmaceuticalsAntisense rnai therapeutics market company profilesBenitec biopharma ltdPath holdingsCalando pharmaceuticalsAlnylam pharmaceuticals

vimarsana © 2020. All Rights Reserved.